MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-WB-10-0007166
Allenburys Pharma Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹158.81 Cr
▼ 6% YoY
Net profit · FY 2025
₹1.09 Cr
Net margin 0.7%
EBITDA · FY 2025
₹1.79 Cr
EBITDA margin 1.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.05 Cr
Issued & subscribed
Open charges
₹35 Cr
Satisfied ₹10 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
2
Provident fund records
About Allenburys Pharma Limited
Data last updated:
Allenburys Pharma Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U93020WB2020PLC240519. Its GSTIN is 19AAUCA2154L1Z5 (West Bengal). The company holds 7 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.05 Cr. It is led by directors including Biswajit Pan and Rubi Mukhopadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Block B 79 80 Mehta Building 55 B.R.B Basu Road Kolkata 700001, West Bengal, India – 700001.
As per the financials filed for FY 2025, the company reported a revenue of ₹158.81 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.09 Cr (net margin 0.7%) and EBITDA of ₹1.79 Cr (EBITDA margin 1.1%).
The company has about 2 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹35 Cr and satisfied charges of ₹10 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 4 cases are pending.
Allenburys Pharma Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-WB-10-0007166). For more details, the company can be reached via its website allenburyspharma.com.
Company details
CIN U93020WB2020PLC240519
Registration Number 240519
Incorporation Date 15 October 2020
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-WB-10-0007166
Recognitions & Rankings of Allenburys Pharma
Contact details
Allenburys Pharma Limited's registered office is in Kolkata, West Bengal. Its website is allenburyspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3rd Floor Block B 79 80 Mehta Building 55 B.R.B Basu Road Kolkata 700001, West Bengal, India – 700001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Allenburys Pharma Limited, buy the company report.
Comprehensive company report
Allenburys Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Allenburys Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Allenburys Pharma Limited, buy the company report.
Financials of Allenburys Pharma Limited
FY 2025 filings availableAllenburys Pharma Limited reported revenue of ₹158.81 Cr (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹158.81 Cr ▼ 6%
Net profit · FY 2025
₹1.09 Cr margin 0.7%
EBITDA · FY 2025
₹1.79 Cr margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
EBITDA CAGR growth
1 year
▼ 54%
Revenue fell 6% in the latest year. EBITDA fell 54% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Allenburys Pharma Limited, buy the company report.
Board of directors of Allenburys Pharma Limited
Allenburys Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biswajit Pan Also directs: Alventa Pharma Limited, Aleris Pharmaceuticals Limited, Elder Laboratories Limited and 4 more | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Rubi Mukhopadhyay Also directs: Smith Stanistreet Pharmaceuticals LLP, Alventa Pharma Limited, Aleris Pharmaceuticals Limited and 2 more | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Anand Kumar Parmanandka Also directs: Alventa Pharma Limited, Aleris Pharmaceuticals Limited, Elder Laboratories Limited and 3 more | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Allenburys Pharma Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shree Khatudham Ispat & Power Private Limited | ₹161.2 Cr (FY 2025) | 1822.0% | Raipur, Chhattisgarh, India | |||
| Maxrise Agri Exims Private Limited | ₹161.16 Cr (FY 2025) | 410.0% | Kakinada, Andhra Pradesh, India | |||
| Sharp King Trading Company Private Limited | ₹160.23 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| F2i Nutrition and Health Private Limited | ₹160.16 Cr (FY 2025) | 65.0% | Lane, Fort, Mumbai 400001, Maharashtra, India | |||
| Metro Polyfilms Private Limited | ₹159.12 Cr (FY 2025) | -51.0% | Delhi, India | |||
| Allenburys Pharma Limitedthis company | ₹158.81 Cr (FY 2025) | ₹1.09 Cr | 0.7% | -6.0% | Kolkata, West Bengal, India | |
| Ankit Polyplast Private Limited | ₹158.05 Cr (FY 2025) | 45.0% | New Delhi, Delhi, India | |||
| Nanesh Diamonds Private Limited | ₹157.7 Cr (FY 2025) | -6.0% | Chennai, Tamil Nadu, India | |||
| Upvan Syntex Private Limited | ₹156.21 Cr (FY 2025) | 8.0% | Kolkata, West Bengal, India | |||
| Manwani and Sons Trade Private Limited | ₹156.19 Cr (FY 2025) | -11.0% | Akola, Maharashtra, India | |||
| Rawfert Resources Private Limited | ₹156.16 Cr (FY 2025) | -82.0% | Delhi, India |
To see the full peer comparison of Allenburys Pharma Limited, buy the company report.
Auditor
Allenburys Pharma Limited is audited by H.P. JHUNJHUNWALA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H.P. JHUNJHUNWALA & CO. | FY 2023 | 302139E |
Shareholding
The shareholding of Allenburys Pharma Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Allenburys Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹35 Cr
Satisfied charges
₹10 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2025 | 101208391 | Others | ₹15 Cr | Open | |
| 11 Nov 2025 | 101189774 | Others | ₹20 Cr | Open | |
| 22 Dec 2023 | 100833808 | Indian Bank | ₹10 Cr | Satisfied |
To see the full charge records of Allenburys Pharma Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Allenburys Pharma Limited has 4 court cases on record: 4 filed by Allenburys Pharma. All cases are pending.
Total cases
4
Filed by the company
4
Pending
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 4 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Court case (CN) | Filed by the company against M/S Kumar Medicos and Surgicals and 1 other | Pending |
| District court, Calcutta, West Bengal | Court case (CN) | Filed by the company against M/S Sonu Pharma | Pending |
| District court, Calcutta, West Bengal | Court case (CN) | Filed by the company against individuals | Pending |
| District court, Calcutta, West Bengal | Court case (CN) | Filed by the company against individuals | Pending |
To see the full case history of Allenburys Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Allenburys Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Allenburys Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Alventa Pharma Limited | U24299WB2016PLC225674 |
To see the full group structure of Allenburys Pharma Limited, buy the company report.
GST
Allenburys Pharma has 7 GST registrations: 6 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
7
Active
6
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAUCA2154L1Z5 | West Bengal | Active | 19 Nov 2022 |
| 19AAUCA2154L2Z4 | West Bengal | Active | 23 Nov 2022 |
| 19AAUCA2154L3Z3 | West Bengal | Active | 31 Mar 2023 |
| 19AAUCA2154L4Z2 | West Bengal | Active | 01 Dec 2023 |
To see the full GST registrations and return filing status of Allenburys Pharma Limited, buy the company report.
Recent activity
Allenburys Pharma Limited has 3 board changes on record since 2020: 3 appointments. The latest: Anand Kumar Parmanandka was appointed as Director on 15 Oct 2020.
Charges
A charge registered on 22 Dec 2023 via Charge ID 100833808 with Indian Bank was fully satisfied on 05 Feb 2026.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101208391 was registered on 12 Dec 2025.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101189774 was registered on 11 Nov 2025.
AGM
Allenburys Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Allenburys Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Charges
A charge with Indian Bank amounted to Rs. 10.00 Cr with Charge ID 100833808 was registered on 22 Dec 2023.
Appointed
Anand Kumar Parmanandka was appointed as Director.
Appointed
Biswajit Pan was appointed as Director.
Appointed
Rubi Mukhopadhyay was appointed as Director.
Incorporation
15 Oct 2020
Allenburys Pharma Limited was registered on 15 Oct 2020 with Roc Kolkata I & aged 6 years 15 days as per MCA records.
Frequently asked questions
Allenburys Pharma is an active public limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 October 2020 (6+ years old) and is registered under CIN U93020WB2020PLC240519.
Allenburys Pharma has 3 current directors:
- Biswajit Pan - Director
- Rubi Mukhopadhyay - Director
- Anand Kumar Parmanandka - Director
The latest financial statements of Allenburys Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Allenburys Pharma is 19AAUCA2154L1Z5, registered in West Bengal. The company has 7 GST registrations in all, of which 6 are active and 1 is cancelled or inactive. Other active GSTINs include 19AAUCA2154L2Z4 (West Bengal), 19AAUCA2154L3Z3 (West Bengal), 19AAUCA2154L4Z2 (West Bengal).
The CIN (Corporate Identification Number) of Allenburys Pharma is U93020WB2020PLC240519. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allenburys Pharma has 4 court cases on record: 4 filed by the company. 4 are pending.
Allenburys Pharma was incorporated on 15 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Allenburys Pharma by revenue are Shree Khatudham Ispat & Power Private Limited, Maxrise Agri Exims Private Limited, Sharp King Trading Company Private Limited, F2i Nutrition and Health Private Limited, Metro Polyfilms Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Anand Kumar Parmanandka was appointed as Director on 15 Oct 2020. Biswajit Pan was appointed as Director on 15 Oct 2020. Rubi Mukhopadhyay was appointed as Director on 15 Oct 2020.
Yes, Allenburys Pharma is registered as an MSME under Udyam registration (number: UDYAM-WB-10-0007166).
Allenburys Pharma can be reached through the website allenburyspharma.com. Its registered office is in Kolkata, West Bengal, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages